🔎 Trials Near Me

Utama › Kanser Prostat › Arizona

Kajian klinikal Kanser Prostat di Arizona

42 kajian untuk Kanser Prostat sedang mencari peserta di lokasi di Arizona.

Bandar di Arizona

Teks kajian rasmi (Bahasa Inggeris)

Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer

  • Mayo Clinic in Arizona, Scottsdale
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT06625034

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Banner University Medical Center - Tucson, Tucson
  • University of Arizona Cancer Center-North Campus, Tucson
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Kingman Regional Medical Center, Kingman
  • Cancer Center at Saint Joseph's, Phoenix
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Banner University Medical Center - Tucson, Tucson
  • University of Arizona Cancer Center-North Campus, Tucson
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Mayo Clinic Hospital in Arizona, Phoenix
  • Mayo Clinic in Arizona, Scottsdale
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • Mayo Clinic, Scottsdale
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 29 Sep 2026 · NCT01492972

DESTINY-PANTUMOUR04

  • Research Site, Bullhead City
  • Research Site, Casa Grande
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • The University of Arizona Cancer Center - North Campus ( Site 0073), Tucson
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Chandler
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Gilbert
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Glendale
  • dan 5 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 24 Sep 2026 · NCT07028853

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

  • Mayo Clinic in Arizona, Scottsdale
Mengambil pesertaFasa 2
Umur 18 ke atas · Lelaki · Dikemas kini 23 Sep 2026 · NCT07025369

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Honor Health Research Institute, Scottsdale
Mengambil pesertaFasa 2/3
Umur 18 hingga 100 · Lelaki · Dikemas kini 22 Sep 2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • City of Hope Cancer Center Phoenix, Goodyear
  • University of Arizona Cancer Center, Tucson
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 22 Sep 2026 · NCT07213674

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Phoenix
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 18 Sep 2026 · NCT06952803

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

  • GSK Investigational Site, Phoenix
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Lelaki · Dikemas kini 18 Sep 2026 · NCT06990880

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Mayo Clinic in Arizona - Phoenix ( Site 0044), Phoenix
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 17 Sep 2026 · NCT06925737

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

  • Academic Urology and Urogynecology of Arizona, Peoria
Mengambil pesertaFasa 2
Umur 18 ke atas · Lelaki · Dikemas kini 15 Sep 2026 · NCT07332000

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • Mayo Clinic, Scottsdale
Mengambil peserta
Umur 18 ke atas · Lelaki · Dikemas kini 14 Sep 2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Mayo Clinic- Phoenix, Phoenix
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 11 Sep 2026 · NCT06056830

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

  • HonorHealth, Scottsdale
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 8 Sep 2026 · NCT05800665

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

  • Honor Health Research Institute, Scottsdale
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Lelaki · Dikemas kini 4 Sep 2026 · NCT07567846

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Phoenix
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 26 Ogo 2026 · NCT07611110

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Cancer Center at Saint Joseph's, Phoenix
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 19 Ogo 2026 · NCT04423211

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • Western Regional Medical Center - City of Hope Phoenix Goodyear, Goodyear
  • HonorHealth Research Institute, Scottsdale
  • The University of Arizona Cancer Center - North Campus, Tucson
Mengambil pesertaFasa 2
Umur 18 ke atas · Lelaki · Dikemas kini 17 Ogo 2026 · NCT06842498

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Mayo Clinic, Phoenix
  • Honor Health, Scottsdale
  • Arizona Cancer Center at University of Arizona, Tucson
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • Mayo Clinic, Phoenix
Mengambil pesertaFasa 1
Umur 18 hingga 100 · Lelaki · Dikemas kini 13 Ogo 2026 · NCT05519449

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #108, Goodyear
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT06545942

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Cancer Center at Saint Joseph's, Phoenix
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 14 Jul 2026 · NCT06592924

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

  • Mayo Clinic in Arizona, Scottsdale
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Lelaki · Dikemas kini 8 Jun 2026 · NCT05045066

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • Mayo Clinic Arizona, Scottsdale
Mengambil pesertaFasa 4
Umur 18 hingga 100 · Lelaki · Dikemas kini 4 Jun 2026 · NCT05803941

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • Mayo Clinic, Phoenix
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06395519

Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy

  • Arizona Urology Specialists, Tucson
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 19 Feb 2026 · NCT06450106

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • HonorHealth Research Institute, Scottsdale
  • The University of Arizona Cancer Center, Tucson
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06778863

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • Cancer Center at Saint Joseph's, Phoenix
Mengambil pesertaFasa 2
Umur 18 ke atas · Lelaki · Dikemas kini 29 Jan 2026 · NCT05806515

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

  • Scottsdale Medical Imaging, LLC, Scottsdale
Mengambil pesertaFasa 4
Umur 18 hingga 64 · Semua jantina · Dikemas kini 22 Jan 2026 · NCT04373564

4-aminopyridine Treatment for Nerve Injury

  • University of Arizona, Tucson
Mengambil pesertaFasa 2/3
Umur 45 hingga 75 · Lelaki · Dikemas kini 17 Dis 2025 · NCT03701581

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 111, Tucson
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Nov 2025 · NCT05914116

Understanding of Genetics by Men at Risk for Prostate Cancer

  • Mayo Clinic, Phoenix
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 40 hingga 95 · Lelaki · Dikemas kini 6 Nov 2025 · NCT04550845

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.